| Bioactivity | RGT-018 is a potent and orally active SOS1 inhibitor with anti-tumor effects. RGT-018 exerts anti-cancer cell proliferation activity by inhibiting KRAS activation[1]. |
| CAS | 2794934-49-7 |
| Formula | C27H24F3N7O2 |
| Molar Mass | 535.52 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Fei Xiao, et al. "Discovery of RGT-018: A Potent, Selective, and Orally Bioavailable SOS1 Inhibitor for KRAS-Driven Cancers." Molecular Cancer Therapeutics (2024): OF1-OF14. |
RGT-018
CAS: 2794934-49-7 F: C27H24F3N7O2 W: 535.52
RGT-018 is a potent and orally active SOS1 inhibitor with anti-tumor effects. RGT-018 exerts anti-cancer cell proliferat
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.